Pharmacokinetics of nasal fentanyl

Journal of Pharmacy Practice and Research

Volumn 33, Issue 1, 2003, Pages 59-63

  Lim, Stephen C B ^a,c   Paech, Michael J ^a,b,d   Sunderland, V Bruce ^a,c   Roberts, Malcolm J ^a,c   Banks, Samantha L ^a   Rucklidge, Matthew W M ^a  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d Department of Anaesthesia ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MORPHINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HUMAN; PH; POSTOPERATIVE PERIOD;

EID: 0037361216     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr200333159     Document Type: Article

References (21)

1. Striebel HW, Koenigs D, Kramer J. Postoperative pain management by intranasal demand-adapted fentanyl titration. Anesthesiology 1992; 77: 281-5.
2. Striebel HW, Oelmann T, Spies C, Brummer G. Patient-controlled intranasal analgesia (PCINA) for the management of postoperative pain - pilot study. J Clin Anesthesia 1996; 8: 1-8.
3. Galinkin JL, Fazi LM, Guy RM, Chiavacci RM, Kurth CD, Shah UK, et al. Use of IN fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia. Anesthesiology 2000; 93: 1378-83.
4. Striebel HW, Pommerening J, Rieger A. Intranasal fentanyl titration for postoperative pain management in an unselected population. Anaesthesia 1993; 48: 753-7.
5. O'Neil G, Paech M, Wood F. Preliminary clinical use of a patient-controlled intranasal analgesia (PCINA) device. Anaesth Intensive Care 1997; 25: 408-12.
6. Toissant S, Maidl J, Schwagmeier R, Striebel HW. Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief. Can J Anesth 2000; 47: 299-302.
7. Striebel HW, Romer M, Phillipi W, Schwagmeier R. Ein neues Gerat zur patientenkontrollierten intranasalen Analgesie. Der Schmerz 1995; 9: 84-8.
8. Gizurarson S. The relevance of nasal physiology to design of drug absorption studies. Adv Drug Deliv Rev 1993; 11: 329-47.
9. Schwagmeier R, Oelmann T, Dannapel T, Striebel HW. Patientenakzeptanz gegenuber der patientkontrollierten intranasalen analgesie (PCINA). Anaesthetist 1996; 45: 231-9.
10. Striebel HW, Kramer J, Luhmann I et al. Pharmacokinetics of intranasal fentanyl. Der Schmerz 1993; 7: 122-5.
11. Fryirsa B, Woodhouse A, Huang JL, Dawson M, Mather LE. Determination of subnanogram concentration of fentanyl in plasma by gas chromatographymass spectrometry: comparison with standard radioimmunoassay. J Chromatog B 1997; 688: 79-85.
12. Rowland M, Tozer TN. Clinical Pharmacokinetics, Concepts and Applications. 2nd ed. Philadelphia: Lea and Febiger; 1989. p. 469-71.
13. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 1988; 67: 329-37.
14. American Society of Health-System Pharmacists. Fentanyl citrate monograph, In: AHFS Drug Information. Bethesda, Maryland, USA; 2001. p. 1997-2003.
15. Varvel JR, Shafer SL, Hwang SS, Coen PA, Stanski DR. Absorption characteristic of transdermally administered fentanyl. Anesthesiology 1989; 70: 928-34.
16. Streisand JB, Varvel JR, Stanski DR, Le Maire L, Ashburn MA, Hague BI, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991; 75: 223-9.
17. Mather LE, Woodhouse A, Ward ME, Farr SJ, Rubsamen RA, Eltherington LG. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. Br J Clin Pharmacol 1998; 46: 37-43.
18. Hirai S, Yashika T, Matsuzawa T, Mima H. Absorption of drugs from the nasal mucosa of rat. Int J Pharm 1981; 7: 317-25.
19. Chien YW, Chang SF. Intranasal Drug Delivery for Systemic Medications. CRC Critical Reviews in Therapeutic Drug Carrier Systems. 1987; 4: 67-194.
20. Huang C, Kimura R, Nassar R, Hussein AA. Mechanism of nasal absorption of drugs I: physicochemical parameters influencing the rate of in-situ nasal absorption of drugs in rats. J Pharm Sci 1985; 74: 608-11.
21. Hussein AA, Bawarshi-Nassar R, Huang CH. Physicochemical consideration in intranasal drug administration. In: Chien YW, editor. Transnasal Systemic Medications. Amsterdam: Elsevier; 1985, p.121.